Reaching European cancer patients – faster
We help biopharma companies, oncologists and CROs unlock access to cancer patients across Europe – digitally enabled, nurse-delivered care that helps patients start therapy sooner and stay on treatment longer.
Widening patient access. Connecting therapy to outcomes.
The challenge in cancer isn’t just innovation, it is also implementation. As more patients are diagnosed and treatment complexity increases, getting the right medicine to the right patient, at the right time, is more important than ever.
Sciensus delivers a faster, smarter route from trial to treatment, including in-home care, helping patients start therapy sooner, stay on it longer, and get better outcomes from every dose.
Driven by our expertise in the cancer space
Leveraging over 30 years of clinical experience, deep therapeutic expertise, and personalised digital innovation, we help biopharma and healthcare systems bring cancer treatments to patients.
0 %
satisfaction rate among cancer patients
+ 0
different cancer regimens (oral medications, injectables, immunotherapy)
+ 0
referring oncology specialists
+ 0
relationships with hospitals, clinics and wholesalers
Working with Sciensus has been a genuinely collaborative partnership. As a clinician, I value their work. They not only understand the complexity of cancer care but also deliver it in a way that supports both patients and the wider healthcare system. They maintain the quality and continuity needed to deliver effective medicines and treatment.
Professor Chris Nutting (MBBS MBA FRCP FRCR MD PhD FMedSci)
What we deliver for cancer partners
Therapy awareness and activation
Biopharma connections to over 4,000 healthcare points of care – helping raise awareness and getting eligible patients onto treatment, fast.
Early access programmes
Accelerated access to therapy through tailored Early Access Programmes.
Decentralised clinical trials
Accelerated access to therapy through decentralised trials and recruitment support across EU markets.
Wholesale and distribution
Secure, specialist delivery supply chains across Europe – to hospitals, pharmacies, and directly to patients.
Digital patient support
Tech-enabled, nurse-supported programmes tailored for oncology – from onboarding to long-term engagement.
Evidence generation
Real-world insights from millions of patient touchpoints, supporting outcomes reporting, HTA submissions, and PSP optimisation.
Care that connects: experiences from patients and clinicians
Track outcomes. Improve experiences. Digitally.
An innovative app that empowers patients to manage their health journey. See how patients are responding to medication in real-world settings through PROMs, symptom and QoL logs, and interaction with personalised treatment content.
Sciensus Cancer Companion app
An innovative app that empowers patients to manage their health journey. See how patients are responding to medication in real-world settings through PROMs, symptom and QoL logs, and interaction with personalised treatment content.
Sciensus Cancer Companion PRO
SciensusPRO is a comprehensive digital portal that enables clinicians to monitor real-time patient-reported outcomes, prioritise patient care, and make data-driven decisions to enhance treatment effectiveness and patient well-being.
Ensure your cancer treatments reach patients where they are
Whether you’re launching a new therapy, scaling access across Europe, or designing a hybrid patient journey – Sciensus helps get treatments to patients who need them. Request a complimentary consultation and explore how we can help.
I feel extremely well cared for by all the Sciensus team. They are professional but friendly and have made this whole experience so much better than it would have otherwise been.
Patient satisfaction survey 2025
Patient-centric care
Multi-disciplinary teams
Expert-led care
Get in touch
Thank you for your interest in Sciensus. Whether you’re seeking information, partnership opportunities, or want to refer a patient, our dedicated team is here to assist you. Please fill out the form on the right, and one of our multi-lingual representatives will get in touch with you promptly.